Madrigal Pharmaceuticals, Inc. (MDGL)

Last Closing Price: 267.04 (2024-03-28)

Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Madrigal Pharmaceuticals, Inc. (MDGL) Revenue data is not available for the most recently reported fiscal year, ending 2023-12-31.

Figures for fiscal year ending 2023-12-31
Income Statement Financials
Revenue
--
$-373.63M
--
--
$380.50M
$-380.50M
$6.87M
$-373.63M
$-373.63M
$-373.63M
$-373.63M
$-373.63M
$-373.63M
$-380.50M
$-377.56M
18.69M
18.69M
$-19.99
$-19.99
Balance Sheet Financials
$637.28M
$1.55M
$3.27M
$640.55M
$118.55M
$115.48M
$116.67M
$235.21M
$405.33M
$405.33M
$405.33M
19.88M
Cash Flow Statement Financials
$-324.23M
$-502.52M
$595.12M
$331.55M
$99.92M
$-231.63M
$49.73M
--
--
Fundamental Metrics & Ratios
5.38
--
--
0.22
0.28
--
--
--
--
--
--
$-325.71M
--
--
--
--
--
--
--
-92.18%
-92.18%
-58.33%
-71.74%
$20.39
$-17.43
$-17.35